The global glycomics/glycobiology market size is expected to reach USD 5.24 billion by 2032, according to a new study by Polaris Market Research. The report “Glycomics/Glycobiology Market Share, Size, Trends, Industry Analysis Report, By Product (Enzymes, Kits, Reagents, and Instruments); By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Rising investments and implementation on glycomics research by both government and private organizations, high development of many novel drugs & therapeutics, and progress in proteomics are key factors boosting global market growth.
In the last decades, glycomics has gained high popularity as an emerging field of research and has a wide range of applications in oncology, diagnostics, drug discovery, and immunology and is also being used in determining cancer cells and regulating cell regulation. Thus, the market is expected to grow significantly and have huge opportunities shortly. For instance, in April 2022, Bruker announced the availability of its new novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF flex combined with unbiased lipidomics, metabolomics, and glycomics tissue imaging.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/glycomics-glycobiology-market/request-for-sample
The growing prevalence of cancer and other related diseases among people worldwide has led to the rising use of glycobiology in research activities for cancer treatment, because of the relevance of surface glycan in both neoplastic and metastatic characteristics of tumor cells present in human body. Lung cancer amounted to a leading number of cancer deaths, with a total estimated 1.8 million deaths followed by colorectal with about 1 million deaths.
Furthermore, precision medicine has rapidly grown in recent years and many large pharma and biotech companies are investing larger funds to develop various targeted drugs, which can be effectively used for a specific patient group. In addition, a researcher has also shown that the mutation in glycosyltransferases or other related enzymes alters the glycome and also causes over 100 types of human congenital disorders.
Glycomics/Glycobiology Market Report Highlights
Polaris Market Research has segmented the glycomics/glycobiology market report based on product, application, end-use, and region:
Glycomics/Glycobiology, Product Outlook (Revenue - USD Billion, 2019 - 2032)
Glycomics/Glycobiology, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Glycomics/Glycobiology, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
Glycomics/Glycobiology, Regional Outlook (Revenue - USD Billion, 2019 - 2032)